Yeungnam Univ J Med.
2019 Sep;36(3):192-200. 10.12701/yujm.2019.00269.
Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
- Affiliations
-
- 1Department of Radiation Oncology, School of Medicine, Kyungpook National University, Daegu, Korea. mkkang@knu.ac.kr
- 2Department of Radiation Oncology, Yeungnam University College of Medicine, Daegu, Korea.
- KMID: 2460187
- DOI: http://doi.org/10.12701/yujm.2019.00269
Abstract
- Stereotactic body radiotherapy (SBRT) is an advanced form of radiotherapy (RT) with a growing interest on its application in the treatment of hepatocellular carcinoma (HCC). It can deliver ablative radiation doses to tumors in a few fractions without excessive doses to normal tissues, with the help of advanced modern RT and imaging technologies. Currently, SBRT is recommended as an alternative to curative treatments, such as surgery and radiofrequency ablation. This review discusses the current status of SBRT to aid in the decision making on how it is incorporated into the HCC management.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Small Hepatocellular Carcinoma Who Showed Complete Response by Combined Therapy of Transarterial Chemoembolization and Stereotactic Body Radiotherapy
- Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
- Stereotactic Body Radiotherapy for Early Stage Lung Cancer
- Differences in radiotherapy application according to regional disease characteristics of hepatocellular carcinoma
- Recent developments in radiotherapy for hepatocellular carcinoma
